A proteomic approach to identify biomarkers to discriminate between chronic rejection and immunological tolerance after liver transplantation
Project/Area Number |
26460450
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Human pathology
|
Research Institution | Kyoto University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
鶴山 竜昭 京都大学, 医学研究科, 特定教授 (00303842)
|
Project Period (FY) |
2014-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2016: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Keywords | 肝移植 / 慢性拒絶 / 免疫寛容 / バイオマーカー / 慢性拒絶反応 / プロテオーム解析 / 早期診断 / 細胆管 |
Outline of Final Research Achievements |
Chronic rejection (CR) remains a serious cause of liver allograft dysfunction. The biomarkers to predict the patients’ outcome are necessary to determine the immunosuppressive strategies early after transplantation. Using antibody microarray, we provided evidence about the down-expression of STK17A in CR. STK17A is a member of the death-associated protein kinase family. Its biological significance in the liver is unknown. We found a new location for STK17A in bile canaliculi. During the evolution of CR, the staining pattern of bile canalicular STK17A gradually changed from diffuse linear to focal intermittent. The alteration in the expression pattern of STK17A in bile canaliculi may help identify early stages of the disease. We applied liver tissue samples of tolerance and CR to liquid chromatography mass spectrometry to investigate the biomarker to discriminate between the tolerance and CR early after LT and the validation study for candidate proteins has been undertaken.
|
Report
(4 results)
Research Products
(18 results)
-
[Journal Article] Antibodies that React with Liver Tissue and Donor-specific anti-HLA Antibodies in Pediatric Idiopathic Posttransplantation Hepatitis2017
Author(s)
Hirata Y, Yoshizawa A, Egawa H, Ueda D, Okamoto S, Okajima H, Yurugi K, Hishida R, Hirai H, Miyagawa-Hayashino A, Maekawa T, Haga H, Uemoto S
-
Journal Title
Transplantation
Volume: 印刷中
Issue: 5
Pages: 1074-1083
DOI
Related Report
Peer Reviewed / Acknowledgement Compliant
-
[Journal Article] Loss of Hep Par 1 immunoreactivity in the livers of patients with carbamoyl phosphate synthetase 1 deficiency2016
Author(s)
Yamaguchi M, Kataoka TR, Shibayama T, Fukuda A, Nakazawa A, Minamiguchi S, Sakurai T,Miyagawa-Hayashino A, Yorifuji T, Kasahara M, Uemoto S, Haga H
-
Journal Title
Pathol Int
Volume: 66
Issue: 6
Pages: 333-336
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
[Journal Article] Necrostatin-1 protects against reactive oxygen species (ROS)-induced hepatotoxicity in acetaminophen-induced acute liver failure.2014
Author(s)
Takemoto K, Hatano E, Iwaisako K, Takeiri M, Noma N, Ohmae S, Toriguchi K, Tanabe K, Tanaka H, Seo S, Taura K, Machida K, Takeda N, Saji S, Uemoto S, Asagiri M.
-
Journal Title
FEBS Open Bio.
Volume: 6
Issue: 2
Pages: 777-87
DOI
NAID
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
[Journal Article] Neutrophil gelatinase-associated lipocalin in idiopathic pulmonary fibrosis.2014
Author(s)
Ikezoe K, Handa T, Mori K, Watanabe K, Tanizawa K, Aihara K, Tsuruyama T, Miyagawa-Hayashino A, Sokai A, Kubo T, Muro S, Nagai S, Hirai T, Chin K, Mishima M
-
Journal Title
Eur Respir J
Volume: 43
Issue: 6
Pages: 1807-1809
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-